OCP and Ethiopia in $3.7 Billion Fertilizer Project


Leading phosphate exporter Office Cherifien des Phosphates (OCP) has signed an agreement with the Ethiopian Ministry of Public Enterprise to build a $3.7 billion fertilizer plant in the east African country. OCP, which is 95% owned by the Moroccan government, said the "game-changing partnership" is based on a common vision between Morocco and Ethiopia for sustainable agricultural development across Africa and reinforces economic ties between the two countries.
The first phase of the project will see $2.4 billion invested in a plant in Dire Dawa, 250 kilometers east of the capital Addis Ababa, to produce 2.5 million t/y of fertilizer. Start-up is slated for mid-2022. Part of the investment will also be spent on developing infrastructure at Djibouti harbor to handle the phosphoric acid imported from OCP in Morocco. Potash and ammonia feedstocks will be sourced from Ethiopia.
OCP said 60% of the first-phase investment will come from debt financing with the rest in equal shares from the two partners. A second-phase investment of $1.3 billion will be made to raise capacity to 3.8 million t/y by 2025. The plant’s output is expected to more than meet all of Ethiopia's fertilizer demand with the excess being exported, aided by a new railway line that will connect the plant to neighboring countries.
Ethiopia's agricultural sector is said to account for 45% of the country's GDP and 90% of its exports. According to the World Bank, Ethiopia is the second most populous country in Sub-Saharan Africa with GDP growth of 9.6% in 2015.
most read

Orion Announced Plans to Shut Down Carbon Black Plants
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.

Oxea Appoints Michael McHenry as New Chief Executive Officer
German oxo-chemicals manufacturer Oxea has appointed Michael McHenry as its new CEO with effect from August 15, 2025.

Boehringer Ingelheim Paves the Way for Important Market Launches
Boehringer Ingelheim recorded positive growth in the first half of 2025 with an increase in Group sales of 6.3% to € 14 billion.

Roche and Zealand Pharma Collaborate on Weight Management Drug
Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

BASF Divests Two Joint Ventures in China
BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.